Literature DB >> 16864641

Invasive pulmonary and central nervous system aspergillosis after near-drowning of a child: case report and review of the literature.

Piet Leroy1, Annick Smismans, Tatjana Seute.   

Abstract

Invasive aspergillosis is extremely rare in immunocompetent children. Here we describe the clinical, radiologic, and laboratory course of fatal invasive pulmonary and central nervous system aspergillosis in a previously healthy child after a near-drowning incident with submersion in a pond. Findings were compared with data from the literature, which is reviewed. Serum Aspergillus galactomannan levels were determined retrospectively and were compared with the results of routine microbiological and radiologic examinations, showing a significant diagnostic and therapeutic delay of the routine diagnostic approach in comparison with the use of the Aspergillus galactomannan assay. This delay may have contributed to the fatal course. Serial determination of serum Aspergillus galactomannan may be helpful in diagnosing invasive aspergillosis early in case of pulmonary disease after near-drowning and may contribute to an early appropriate treatment. Currently voriconazole, eventually in combination with caspofungin, should be considered as the drug of choice in the management of invasive aspergillosis after near-drowning.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864641     DOI: 10.1542/peds.2005-2901

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis.

Authors:  A Biglino; P Crivelli; E Concialdi; C Bolla; G Montrucchio
Journal:  Infection       Date:  2008-10-14       Impact factor: 3.553

2.  A challenging case of invasive pulmonary aspergillosis after near-drowning: a case report and literature review.

Authors:  Jeffrey D Jenks; Michael Preziosi
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2015-09-01

Review 3.  [Fungal infections of the central nervous system in the immunocompetent host].

Authors:  K Tintelnot; G S de Hoog; G Haase
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 4.  Freshwater Fungal Infections.

Authors:  Dennis J Baumgardner
Journal:  J Patient Cent Res Rev       Date:  2017-01-31

5.  Invasive pulmonary aspergillosis caused by Aspergillus versicolor in a patient on mechanical ventilation.

Authors:  Mv Pravin Charles; Mariya Joseph Noyal; Joshy M Easow; Ravishankar M
Journal:  Australas Med J       Date:  2011-11-30

Review 6.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

7.  Immunoproteomics based identification of thioredoxin reductase GliT and novel Aspergillus fumigatus antigens for serologic diagnosis of invasive aspergillosis.

Authors:  Li-ning Shi; Fang-qiu Li; Mei Huang; Jing-fen Lu; Xiao-xiang Kong; Shi-qin Wang; Hai-feng Shao
Journal:  BMC Microbiol       Date:  2012-01-18       Impact factor: 3.605

8.  Pseudomembranous aspergillar tracheobronchitis in a non-neutropenic critically ill patient in the intensive care unit.

Authors:  Sameen Khalid; Fnu Asad-Ur -Rahman; Aamer Abbass; Sigfredo Aldarondo; Khalid Abusaada
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-03-31

Review 9.  Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients.

Authors:  R J Trof; A Beishuizen; Y J Debets-Ossenkopp; A R J Girbes; A B J Groeneveld
Journal:  Intensive Care Med       Date:  2007-07-24       Impact factor: 17.440

10.  Invasive Aspergillosis After Non-Fatal Drowning.

Authors:  Shunichi Koide; Yoshiro Hadano; Shinji Mizuochi; Hitoshi Koga; Hisashi Yamashita
Journal:  Int Med Case Rep J       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.